Cangrelor tetrasodium
Cangrelor tetrasodium is a reversible and selective antagonist of platelet P2Y12, with prompt and potent antiplatelet effects.cangrelor, a non-sepesific GPR17 antagonist, alleviates pulmonary fibrosis partly by inhibiting macrophage inflammation in mice.
Product Specifications
CAS Number
163706-36-3
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
864.29
Molecular Weight
C17H21Cl2F3N5Na4O12P3S2
Notes
Research use only, not for human use.
Receptor
GPR17
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
RA0622-01 100 µg
Rafivirumab (Biosimilar Reference Antibody) (Rabies Virus Antigenic Site III)
Ask
View Details 
RA0622-02 1 mg
Rafivirumab (Biosimilar Reference Antibody) (Rabies Virus Antigenic Site III)
Ask
View Details 
RA0622-03 5 mg
Rafivirumab (Biosimilar Reference Antibody) (Rabies Virus Antigenic Site III)
Ask
View Details 
RA0622-04 10 mg
Rafivirumab (Biosimilar Reference Antibody) (Rabies Virus Antigenic Site III)
Ask
View Details RA0622-05 25 mg
Rafivirumab (Biosimilar Reference Antibody) (Rabies Virus Antigenic Site III)
Ask
View Details RA0622-06 50 mg
Rafivirumab (Biosimilar Reference Antibody) (Rabies Virus Antigenic Site III)
Ask
View Details